Table 3 Demographics and lung function parameters in healthy and allergic athletes
Athletes with rhinitis | Athletes with asthma | Athletes without asthma or allergy | |
|---|---|---|---|
No. of subjects | 30 | 27 | 146 |
Males/Females | 19/11 | 17/10 | 97/41 |
Age[years] (median; range) | 26 | 25 | 26 |
Baseline FEV1 [% predicted] (median;range) | 105 (80 – 129) | 99 (66 – 117) | 103 (81 – 125) |
ΔFEV1post-salbutamol [%] (median; range) | 4 (0 – 10) | 10.5 (2 – 26)a | 4 (0 – 20) |
FVC [% predicted] (median; range) | 101 (92 – 120) | 108 (77 – 125) | 106.5 (85 – 134) |
FEV1/FVC (median; range) | 0.81 (0.72 – 0.92) | 0.77 (0.63 – 0.86) | 0.81 (0.61 – 0.97) |
MEF 25-75 [% predicted] (median; range) | 98 (54 – 156) | 82 (38 – 122)b | 99 (42 – 170) |